*Sponsored by Lifewater Media. Please see disclosures below. |
| Reasons to Keep an Eye on "QNTM" |
| | | | | Hey Folks, Our idea from last night is on the move! Here are a few fundamental reasons to take a look at QNTM this morning... 1. Advancement in Multiple Sclerosis Treatment: Quantum BioPharma received ethics approval in Australia for a Phase-1 study of Lucid-MS, a novel treatment for Multiple Sclerosis, marking a significant step in their clinical development. 2. Strong Pipeline: Quantum BioPharma's pipeline includes promising candidates like FSD201 for inflammatory diseases, Lucid-Psych for mental health disorders, and Lucid-MS for neurodegenerative disorders. 3. Experienced Leadership: Marketing experts Kevin Harrington and Gerry David are leading the market launch of unbuzzd™, bringing valuable experience to the company's commercialization efforts. 4. Positive Analyst Coverage: Analysts have set an average price target (according to MarketWatch) of $12.80 for QNTM, indicating confidence in the company's growth potential. 5. Innovative Product Launch: The company successfully launched unbuzzd™, a formulation designed to expedite alcohol metabolism, now available on Amazon. Anyways...
That's all for now! Until Next Time, -Damian | P.S. Want our text alerts? Text "ZIPTRADER" to 1-(855)-228-1598 to sign up!
(standard carrier data/text rates apply) |
|
|
|---|
|
*Sponsored by Lifewater Media. Please see disclosures below. |
|
|---|
|
| | 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA |
| You've received it because you've subscribed to our newsletter or are a member of ZipTraderU. |
| This email was sent to southernstylecooking@gmail.com |
| *SPONSORED CONTENT* ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance. Quantum BioPharma Ltd. (QNTM) represents a rebranding, ticker, and composition change of FSD Pharma Inc. (HUGE). ZipTrader has been compensated seventeen thousand five hundred USD by ACH Bank Transfer by Lifewater Media to distribute media via email and SMS for Quantum BioPharma Ltd. (QNTM) from March 30, 2025 to March 31, 2025. ZipTrader may receive additional campaigns in the future by Lifewater Media to distribute media for Quantum BioPharma Ltd. (QNTM). ZipTrader has been compensated seventeen thousand five hundred USD by ACH Bank Transfer by Lifewater Media to distribute media via email and SMS for Quantum BioPharma Ltd. (QNTM) from December 19, 2024 to December 20, 2024. ZipTrader has been compensated forty-two thousand five hundred USD by ACH Bank Transfer by Lifewater Media to distribute media via YouTube, email, and SMS for Quantum BioPharma Ltd. (QNTM) from October 21, 2024 to October 23, 2024. ZipTrader has been compensated thirty-two thousand USD by ACH Bank Transfer by Lifewater Media to distribute media via YouTube, email, SMS, X/Twitter, Facebook, and Discord for Quantum BioPharma Ltd. (QNTM) from August 29, 2024 to August 30, 2024. ZipTrader has been compensated eighteen thousand USD by ACH Bank Transfer by Lifewater Media to distribute media via email, SMS and Discord for FSD Pharma Inc. (HUGE) from August 8, 2024 to August 9, 2024. As a result of this advertisement and other marketing efforts, ZipTrader may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of ZipTrader do not hold a position in Quantum BioPharma Ltd. (QNTM). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Quantum BioPharma Ltd. (QNTM), increased trading volume, and possibly an increased share price of Quantum BioPharma Ltd. (QNTM), which may or may not be temporary and decrease once the marketing arrangement has ended. |
| BY READING THIS EMAIL & ALL ZIPTRADER CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZIPTRADER LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk. Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. TRADING IS RISKY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered here if you are not prepared with the reality that most fail. We reserve the right to have affiliate relationships with advertisers/sponsors. See Full Terms of Service.See Our Advertisement/Sponsored Stock Disclaimer. |
| | |
|
|
|---|
|
|
|
No comments:
Post a Comment